AVROBIO, Inc. (14)

Browse by Contract Category

Contracts

Underwriting Agreement, dated November 19, 2020, between AVROBIO, Inc. Morgan Stanley & Co. LLC and Cowen and Company, LLC, as representatives of the several underwriters named... (Filed With SEC on November 20, 2020)
Separation Agreement and Release, by and between the Registrant and Birgitte Volck, M.D., Ph.D., dated July 16, 2020 (Filed With SEC on August 6, 2020)
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 16, 2020)
Amendment No. 1 to License Agreement, by and between the Registrant and BioMarin Pharmaceutical Inc., dated February 21, 2018 (Filed With SEC on March 16, 2020)
First Amendment to the AVROBIO, Inc. 2018 Stock Option and Incentive Plan (Filed With SEC on June 9, 2020)
Amendment No. 2 to License Agreement, by and between the Registrant and BioMarin Pharmaceutical Inc., dated January 7, 2020 (Filed With SEC on March 16, 2020)
Employment Agreement, by and between the Registrant and Deanna Petersen, dated September 1, 2018 (Filed With SEC on March 16, 2020)
Underwriting Agreement, dated February 12, 2020, between AVROBIO, Inc., and Morgan Stanley & Co. LLC and Cowen and Company, LLC, as representatives of the several underwriters... (Filed With SEC on February 13, 2020)
Underwriting Agreement, dated July 16, 2019, between AVROBIO, Inc. Morgan Stanley & Co. LLC and Cowen and Company, LLC, as representatives of the several underwriters named therein (Filed With SEC on July 17, 2019)
Employment Agreement, by and between the Registrant and Steven Avruch, dated December 17, 2018 (Filed With SEC on March 25, 2019)
Consulting Agreement, by and between the Registrant and Birgitte Volck, M.D., Ph.D., dated December 17, 2018 (Filed With SEC on March 25, 2019)
Employment Agreement, by and between the Registrant and Birgitte Volck, M.D., Ph.D., dated December 17, 2018 (Filed With SEC on March 25, 2019)
Separation Agreement and Release, dated January 8, 2019, by and between the Company and Katina Dorton (Filed With SEC on January 11, 2019)
Separation Agreement and Release, dated January 10, 2019, by and between the Company and Nerissa Kreher, M.D (Filed With SEC on January 11, 2019)